Therapeutic Applications of Quadruplex Nucleic Acids

Therapeutic Applications of Quadruplex Nucleic Acids

By (author) 

Free delivery worldwide

Available. Dispatched from the UK in 4 business days
When will my order arrive?


The study of G-quadruplexes has emerged in recent years as an important focus of research in nucleic acids. This is now a rapidly growing area, not least because of its potential as a novel approach to cancer therapeutics, and there is much current activity on the design of quadruplex-selective small-molecule ligands and the study of their cellular effects. This timely publication gives a uniquely integrated view of quadruplex nucleic acids that will be a major resource in future drug-discovery strategies. Therapeutic Applications of Quadruplex Nucleic Acids provides a single comprehensive survey that describes and assesses recent advances in quadruplex therapeutics and targeting strategies. It also covers the underlying fundamentals of such topics as quadruplex structure, small-molecule recognition, biological roles of genomic quadruplexes, and quadruplex informatics.
Written by a world leader in this field, this book is a vital resource for researchers in medicinal chemistry, chemical biology, structural biology, drug discovery, and pharmacology in cancer and other therapeutic areas, as well as for chemists and biologists working on nucleic acids, and will be useful for both active researchers and students in these areas.
show more

Product details

  • Hardback | 208 pages
  • 193.04 x 236.22 x 17.78mm | 476.27g
  • Academic Press Inc
  • San Diego, United States
  • English
  • 0123751381
  • 9780123751386
  • 2,118,848

Table of contents

* Intro - history and milestones* Fundamentals of DNA and RNA quadruplex structure and stability* Quadruplexes as therapeutic targets for telomeres and relationship to telomerase and telomere maintenance* Genomic DNA and RNA quadruplexes - involvement in gene expression and potential as therapeutic agents* Quadruplex targets and human disease - applicability in cancer and infectious disease, including oncogene targets such as c-myc and c-kit* Quadruplex ligands - chemistry and design - selectivity and assays* Quadruplex ligands - basic biology and assays indirect and direct* Quadruplex ligands - pharmacology and druggability, ligands in clinical trial and pre-clinical trial development* Synthetic quadruplexes and drugs - therapeutic aptamers, including thrombin, STAT3 binding, nucleolin binding* Future directions and conclusions
show more

About Stephen Neidle

Stephen Neidle, DSc, PhD, ARCS, FRSC, Director of Cancer Research UK Biomolecular Structure Group, Director of the Centre for Cancer Medicines, Professor of Chemical Biology, The School of Pharmacy, University College London, UK
show more